Anne Douar

Company: Vivet Therapeutics

Job title: Chief Development Officer

Seminars:

Developing a Strategy for Re-Administration of AAV Gene Therapies 3:15 pm

Discuss the concerns surrounding immune responses to AAV vectors Outline the importance of shifting away from a ‘one-and-done’ approach How to develop a successful strategy to enable re-administration of gene therapiesRead more

day: Day Two

Panel Discussion: The Challenges Associated With Scaling-Up to Commercial Manufacturing 11:00 am

Personal experiences in building gene therapy manufacturing facilities Weighing up the choice between in-house manufacturing and outsourcing to CMOs Considerations for deciding between scaling up and scaling out Understanding how to demonstrate comparability when scaling up manufacturing processes Integrating technology into modern gene therapy manufacturing approachesRead more

day: Day One